News by Industry


Releases published in the last 30 days.

Page 1 of 1

Aerobiology Laboratory Announces California Location
Aerobiology Laboratory Announces California Location
3/2/2015 10:00:00 AM
Aerobiology Laboratory Associates, Inc. announced today its newest laboratory location in Huntington Beach, California.  Suzanne Blevins, CEO of Aerobiology stated, “We are very excited to bring our high quality laboratory services to California.  We feel our team of analysts will show the California market what makes Aerobiology different from our competitors.  Our clients …
New Immunotherapy Clinical Trial Begins with Support from SU2C Pancreatic Cancer Dream Team
New Immunotherapy Clinical Trial Begins with Support from SU2C Pancreatic Cancer Dream Team
2/27/2015 2:33:35 PM
Aduro Biotech, Inc. announced the initiation of an investigator-sponsored Phase 2 clinical trial of the company’s immuno-oncology product candidates GVAX Pancreas and CRS-207 in combination with Bristol-Myers Squibb’s Opdivo (nivolumab), a monoclonal antibody against programmed death-1 receptor (PD-1). The first patient has been enrolled in the trial that will be conducted at …
Arif K. Mirza, MD will serve as NEBA Health’s Medical Director
Arif K. Mirza, MD will serve as NEBA Health’s Medical Director
2/26/2015 4:34:42 PM
NEBA® Health , LLC announces today that Arif K. Mirza, MD will serve as NEBA Health’s Medical Director. Howard Merry, President of NEBA Health said: “We are happy to welcome Dr. Mirza to our team. Dr. Mirza was an early NEBA adopter. He’s developed his NEBA practice and can help our users better integrate NEBA into practice.” Dr. Mirza said: “I am very excited to join …
AxoGen, Inc. Announces Presentation of Additional Clinical Data For Avance® Nerve Graft
2/25/2015 8:46:59 AM
AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company with a unique and innovative portfolio of products used to repair injured peripheral nerves, today announced additional clinical data from the RANGER® Study presented by study investigators during the scientific programs at the recent combined annual meetings of the American Association for Hand Surgery (AAHS), …
Head of Medical Company Gentell Announces Expansion of Talent and Resources
2/24/2015 12:03:50 PM
David Navazio, Executive Vice President and Founder of Gentell, Inc. ( ), a leading manufacturer of wound and skin care products, recently announced the opening of a new West Coast sales office to support growing demand, and the appointment of Arnie Andersen as VP Western Sales.   “Our West Coast business has increased significantly, as many nursing homes and …
Australians Gain Access to Breakthrough Treatment for Depression
2/23/2015 2:02:40 PM
Melbourne, Australia, 23 February 2015 – Physicians and patients across Australia now have access to a breakthrough treatment for depression, NeuroStar TMS Therapy®, following its inclusion on the Australian Register of Therapeutic Goods (ARTG).   The non-invasive, non-drug treatment for major depressive disorders is brought to Australia by Neuronetics, Inc. - the …
Aerobiology Laboratory Associates, Inc. Appoints Stacey Murphy as Senior Account Manager for the Northeast/Midwest Regions
Aerobiology Laboratory Associates, Inc. Appoints Stacey Murphy as Senior Account Manager for the Northeast/Midwest Regions
2/12/2015 10:51:21 AM
Aerobiology Laboratory Associates is very pleased to announce the appointment of Stacey Murphy as its new Senior Account Manager supporting clients in the Northeast/Midwest Regions.   Stacey has over eight years of experience in the Environmental Industry.  She has a varied background working for indoor microbiology and environmental chemistry testing laboratories serving …
Sandia Labs anthrax detector takes home national technology transfer award
2/12/2015 9:06:11 AM
Sandia National Laboratories won the Federal Laboratory Consortium’s (FLC) 2015 Award for Excellence in Technology Transfer for a credit-card-size device that can detect bacteria that cause anthrax. BaDx ( Bacillus anthracis Diagnostics) works in places with no power, refrigerated storage or laboratory equipment. It requires minimal or no training and makes anthrax testing …
Crowdfunding Helps Solve Rare Disease Mystery
2/10/2015 11:17:37 AM
Rare diseases — those that affect fewer than one in 200,000 people — are often identified early in life. Some 30 percent of children afflicted by these "orphan diseases" do not live to see their fifth birthday. While the US Orphan Drug Act of 1983 was written into law to promote research on the topic, the cost of identifying the source and progression of these diseases …
Pure-Flo® EnviZion™ Valve awarded 2014 Breakthrough Product of the Year
2/6/2015 9:42:51 AM
ITT (NYSE: ITT) is pleased to announce that the Pure-Flo® EnviZion™ valve, marketed by its Engineered Valves brand, has been named a 2014 Breakthrough Product of the Year by Processing magazine.   The Breakthrough Products of the Year award recognizes products, technologies and services that can make significant contributions in the process industries. Processing magazine’s …
New long-term data to be presented on Elocta(TM) at annual EAHAD meeting
2/5/2015 11:49:59 AM
Swedish Orphan Biovitrum AB (publ) (Sobi) in collaboration with Biogen Idec will present new data from their haemophilia clinical development programmes at the 8th European Association for Haemophilia and Allied Disorders (EAHAD), taking place in Helsinki, Finland, February 11 - 13, 2015. Six abstracts will be presented, including new, interim results from the ASPIRE …
FDA approves first tissue adhesive for internal use
2/5/2015 9:27:00 AM
The U.S. Food and Drug Administration (FDA) today approved TissuGlu, the first tissue adhesive approved for internal use. TissuGlu is a urethane-based adhesive that a surgeon can use to connect tissue flaps made during surgery to remove excess fat and skin or to restore weakened or separated abdominal muscles (abdominoplasty surgery). Connecting the tissue flaps with an …
ENSCO Supports Children’s Robotics Program
ENSCO Supports Children’s Robotics Program
2/4/2015 10:28:22 AM
For the second year, ENSCO is supporting Infamous Robotics LLC through its children’s 2015 Robotics Inventors Club. The elementary age members of this new club are building an autonomous robot called A.N.A. (Autonomous Nurse Assistant) to assist nurses with patients who have Ebola. ANA is designed to intelligently navigate hospitals, and to bring food and other necessary …
AMETEK Advanced Measurement Technology Introduces ORTEC Renaissance 7 Whole Body Counting Software
2/4/2015 9:08:47 AM
The ORTEC Products Group of AMETEK Advanced Measurement Technology has announced the release of RENAISSANCE 7 software that maximizes the productivity of Health Physics Internal Contamination Monitoring when using high-purity germanium (HPGe) and sodium iodide detection systems. New features in RENAISSANCE 7 include compatibility with 64-bit Windows® 7 / 8.1 Professional …
John von Neumann Explains (in 1956) Why Computers Won’t Replace Brains
2/4/2015 9:00:00 AM
A recent EPUB essay, “ Brains and Computers: Amino Acids versus Transistors ” updates the last published work of John von Neumann to guide readers step-by-step through the digital components and processes that constitute the World Wide Web and then through the biological components and processes that constitute the human brain. Von Neumann, principal architect in 1945 of …
GreenWood, Inc. Names Kevin Crittendon as Director of Continuous Improvement
GreenWood, Inc. Names Kevin Crittendon as Director of Continuous Improvement
2/3/2015 12:01:19 PM
Greenville, SC - - February 3, 2015 - - GreenWood, Inc., an integrated maintenance, construction and workforce solutions provider, announces that Kevin Crittendon has joined the company as Director of Continuous Improvement.  For this position, Kevin holds responsibility for maintenance and business process improvements, customer relationship support, standardization of …
Roche commences tender offer for up to 15,604,288 shares of Foundation Medicine, Inc. for $50.00 per share in cash
2/3/2015 10:00:09 AM
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has commenced a cash tender offer for up to 15,604,288 outstanding shares of common stock of Foundation Medicine, Inc. (NASDAQ: FMI) at a price of $50.00 per share. The tender offer is being made pursuant to the previously announced transaction agreement dated as of January 11, 2015 between Foundation Medicine, Inc. …
NXP Semiconductors and Enfucell unveil disruptive biopharmaceutical cold chain monitoring solution
2/3/2015 9:31:52 AM
Biopharmaceutical products (vaccines, hormones, blood) play an increasingly important role in the pharmaceutical industry. To be effective and safe, these products have to be kept in the cold chain from production to administration. Cold chain monitoring is mostly done using either chemical temperature loggers or reusable electronic loggers, both are inadequate. Chemical …

  • « Previous
  • 1
  • Next »